Perrigo Company plc

NYSE:PRGO

Drug Manufacturers - Specialty & Generic

Healthcare
$16.94 -1.97%

-$0.20 today

Market cap
$2.35B
Beta
0.52
P/E (TTM)
-0.8
EPS (TTM)
-$13.10
Dividend yield
11.65%
52W Low $9.23High $28.44

Volume 2.57M

Average 2.96M

PRGO Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Perrigo Company plcNYSE: PRGO

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q2 FY2026 weighted avg shares (diluted) of 139.6M shares rose 1.0% year over year, in line with the +0.9% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.6% from the prior quarter. Over 3 fiscal years it compounded at +1.0% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1.0% holds above the trailing-twelve-month pace of +0.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
139.6M+0.6% QoQ
Last fiscal yearDec 2025
138.5M+0.8% YoY
LTMJun 2026
138.93M+0.9% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.0%——
1 year+0.8%——
3-year CAGR+1.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
138.5M USD
Year-over-year change
+0.8%
4-year CAGR
+0.9%

Weighted Avg Shares (Diluted) vs competitors

How PRGO compares with its peers on the latest reported figures

  • PRGO's LTM Jun 2026 weighted avg shares (diluted) of 138.93M shares is the 4th highest of the 10 companies compared; the peer median is 126.24M shares.
  • Its year-over-year change of +0.9% is the lowest of 10, against a peer median of +2.3%.
  • Over three fiscal years its annual growth of +1.0% compares with a peer median of +6.3%.
PRGO Competitors Peer median
Weighted Avg Shares (Diluted) for PRGO and competitors
Company Period LTM YoY 3-year CAGR
BHCBausch Health Companies Inc.LTM Jun 2026374.23M +0.9%+1.2%
HCMHUTCHMED (China) LimitedLTM Jun 2025174.57M +1.2%+1.0%
ATECAlphatec Holdings, Inc.LTM Mar 2026151.36M +5.1%+13.2%
PRGOPerrigo Company plcLTM Jun 2026138.93M +0.9%+1.0%
SGRYSurgery Partners, Inc.LTM Sep 2026128.32M +1.3%+11.4%
SRRKScholar Rock Holding CorporationLTM Sep 2026126.24M +15.3%+24.4%
HTFLHeartflow, Inc. Common StockLTM Sep 202686.14M +19.4%—
SUPNSupernus Pharmaceuticals, Inc.LTM Jun 202657.4M +2.1%-2.9%
LIVNLivaNova PLCLTM Sep 202656.03M +2.3%+0.6%
TARSTarsus Pharmaceuticals, Inc.LTM Sep 202643.89M +7.8%+19.3%
Peer median (excluding PRGO) 126.24M+2.3%+6.3%

Competitors are the stored peer set for PRGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.14B4.45B4.66B4.37B4.25B
Cost of Revenue2.72B3B2.98B2.83B2.76B
Gross Profit1.42B1.46B1.68B1.54B1.49B
Gross Margin34.2%32.7%36.1%35.3%35.1%
Research & Development122M123.1M122.5M112.2M95.4M
Selling, General & Admin1.11B1.21B1.27B1.11B526.5M
Operating Expenses1.01B1.38B1.53B1.43B1.15B
Depreciation & Amortization312.2M338.6M359.5M325.9M337.5M
EBITDA695.9M355.5M525M433M(797.9M)
EBITDA Margin16.8%8.0%11.3%9.9%-18.8%
Operating Income410.4M78.9M151.9M112.9M343.3M
Operating Margin9.9%1.8%3.3%2.6%8.1%
Interest Income00000
Interest Expense125M156M173.8M187.8M162.5M
Other Income / Expenses(151.7M)(218M)(160.2M)(193.6M)(1.64B)
Income Before Tax258.7M(139.1M)(8.3M)(80.7M)(1.3B)
Pre-Tax Margin6.3%-3.1%-0.2%-1.8%-30.5%
Income Tax Expense389.6M(8.2M)(3.9M)80M104.4M
Net Income(68.9M)(140.6M)(12.7M)(171.8M)(1.43B)
Net Margin-1.7%-3.2%-0.3%-3.9%-33.5%
EPS (Basic)(0.98)(0.97)(0.09)(1.25)(10.29)
EPS (Diluted)(0.98)(0.97)(0.09)(1.25)(10.29)
Weighted Avg Shares133.6M134.5M135.3M137.4M138.5M
Weighted Avg Shares (Diluted)133.6M134.5M135.3M137.4M138.5M

Perrigo Company plc

NYSE:PRGO

Intrinsic Alpha fair value

Locked

Current Price

$16.94

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.